PAIA
AMGN icon

Park Avenue Institutional Advisers’s Amgen AMGN Stock Holding History

Park Avenue Institutional Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,743
Closed -$722K – 33
2016
Q2 		$722K Sell
4,743
-9
-0.2% -$1.4K 0.62% 36
2016
Q1 		$712K Sell
4,752
-134
-3% -$19.9K 0.61% 38
2015
Q4 		$793K Sell
4,886
-158
-3% -$24.8K 0.68% 33
2015
Q3 		$698K Sell
5,044
-74
-1% -$11.7K 0.62% 37
2015
Q2 		$786K Buy
+5,118
New +$820K 0.63% 35

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Park Avenue Institutional Advisers's AMGN Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Amgen (AMGN) in Q3 2016, closing a stake of 4,743 shares — an estimated $722K sold.

Park Avenue Institutional Advisers first reported a position in AMGN in Q2 2015 and held it in 5 quarters. The position peaked at $793K in Q4 2015. 1,517 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Amgen position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 4,743 Amgen shares in Q3 2016, an estimated $722K.
  • Park Avenue Institutional Advisers first reported a position in Amgen in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Amgen position peaked at $793K in Q4 2015.
  • 1,517 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.